Cellular Biomedicine (CBMG) Stock Price & Overview
NASDAQ:CBMG
Current stock price
The current stock price of CBMG is 19.75 null. Today CBMG is down by 0%. In the past month the price increased by 9.72%. In the past year, price increased by 18.41%.
CBMG Key Statistics
- Market Cap
- 384.691M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.82
- Dividend Yield
- N/A
CBMG Stock Performance
CBMG Stock Chart
CBMG Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CBMG. When comparing the yearly performance of all stocks, CBMG turns out to be only a medium performer in the overall market: it outperformed 49.81% of all stocks.
CBMG Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CBMG. CBMG has a bad profitability rating. Also its financial health evaluation is rather negative.
CBMG Earnings
CBMG Forecast & Estimates
CBMG Financial Highlights
Over the last trailing twelve months CBMG reported a non-GAAP Earnings per Share(EPS) of -2.82. The EPS decreased by -17.01% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -16967.89% | ||
| ROA | -58.88% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
CBMG Ownership
About CBMG
Company Profile
Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.
Company Info
Cellular Biomedicine
1345 AVENUE OF AMERICAS 15TH FLOOR
NEW YORK NY 10105
CEO: Bizuo (Tony) Liu
Phone: 347-905-5663
Cellular Biomedicine / CBMG FAQ
What does Cellular Biomedicine do?
Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.
Can you provide the latest stock price for Cellular Biomedicine?
The current stock price of CBMG is 19.75 null.
What is the dividend status of Cellular Biomedicine?
CBMG does not pay a dividend.
What is the ChartMill technical and fundamental rating of CBMG stock?
CBMG has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Who owns Cellular Biomedicine?
You can find the ownership structure of Cellular Biomedicine (CBMG) on the Ownership tab.